Setting Records with Fast Glycan Technology

Mar 17, 2017 | Biopharma, Blogs | 0 comments

There is a lot of talk going around in the lab, and it has to do with the newly released Fast Glycan Labeling and Analysis technology. Where once research analysts needed to set aside days to perform glycan analysis, now takes an hour or so. Glycans are immediately identified by the software – so no need for data interpretation. That’s up to 5x faster than HILIC.

 

Short and simple 60-minute sample prep, followed by a 5-minute high-resolution separation provide immediate glycan identification and quantitation. Since glycan identification is automated, the Fast Glycan technology also eliminates the need for manual database searches while removing the potential for human error from the process.

Bioprocess International recognized our Fast Glycan technology and awarded it the 2016 Best Technology Application – Analytical Award.

Based on magnetic bead technology, it does not require centrifugation or advanced pipetting techniques, making the assay suitable for manual pipetting as well as automation. Researchers can, therefore, quickly detect changes in glycosylation, helping profile glycans that may effect changes in function, efficacy, and clearance of their biologics.

What does this mean for your lab, and how can you test the process yourself? To help you better understand the process, researchers documented the Fast Glycan Labeling and Analysis technology for N-glycosylation analysis in the following application note, “High-Resolution Separation and Identification in Minutes.”

Discover the winning combination for the lab using the PA 800 Plus Pharmaceutical Analysis System.Learn more >

For research use only. Not for use in diagnostic procedures.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

ADC analytics FAQs: Answering the most common questions about ADC characterization

Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing classes of biotherapeutics, combining the targeting specificity of monoclonal antibodies with the potency of cytotoxic payloads. However, this unique architecture also introduces significant analytical complexity. From drug-to-antibody ratio (DAR) distributions and charge variants to conjugation sites and structural modifications, ADCs present multiple, interconnected sources of heterogeneity that must be understood to ensure product quality and performance.

Sterile but toxic: Cereulide detection in food matrices

In a recent webinar, Ming Gao, Ph.D., Senior Research Chemist at Mérieux NutriSciences, explored the growing challenge of cereulide contamination in food products and the analytical strategies needed to detect this heat-stable toxin at trace levels. The session examined how LC-MS/MS can help laboratories overcome the limitations of traditional microbiological screening and meet emerging regulatory requirements.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network